Quote:
Originally Posted by soccertese
http://medcitynews.com/2013/01/fundi...y-says-survey/
assuming the numbers are right in the article.
surprising at how much more funding other diseases get.
Roughly 5.1 million people in the U.S. are believed to have Alzheimer’s Disease. CDC data shows that26.5 million adults have been diagnosed with heart disease, as of 2011. About 1.1 million are infected with HIV, according to the Centers for Disease Control.
With the baby boomer generation at or approaching retirement age, they’ll be at greater risk for Alzheimer’s and other degenerative neurological and eye conditions. It seems like an appropriate time to re-evaluate research and funding priorities. But it’s also encouraging that the U.S. Food and Drug Administration recently permitted a clinical trial using remote monitoring and crowdsourcing for more efficient trial design that could cut down on the cost of recruitment and doing these studies. A group of nonprofits that includes Bright Focus called 21st Century BrainTrust are exploring ways to make clinical trials more efficient by developing ways for people to get a baseline on their cognitive health.
Read more: http://medcitynews.com/2013/01/fundi...#ixzz2JYxYdAuT
|
No source to cite, it's been too long, but I have read many times that China will lead the way in finding the cause and cure for Alz, PD, etc. because of sheer numbers: their looming senior population is so huge that there is no way they can afford to care for them with any dignity or humanity. The numbers are staggering. If we thought we have a big boomer generation facing these illnesses in the US, it pales in comparison to the numbers for China.
For all of those millions of people, and their families, loved ones, and friends, I really hope they discover something significant and useful soon. To me, that would be a more significant milestone in our development as a species that putting a man on the moon. Think of the suffering that could be prevented, it boggles the mind. Keep the faith, whatever yours might be
